MD US ( Pediatrix Medical) long🇺🇸 #invest #MD
Pediatrix Medical Group specializes in providing specialized care for women, newborns, and children.
This includes the following areas of activity:
Neonatal care
Perinatology
Pediatric subspecialties
Other services, including newborn hearing screening, telemedicine development, etc.
The company partners with hospitals, providing clinical department management and staffing services. This includes administrative functions such as billing and HR.
Pediatrix operates in 36 states, partnering with nearly 400 hospitals and bringing together more than 4,400 physicians and clinicians.
The report shows:
EPS $0.53 (forecast $0.42); Revenue $468.84 million (forecast $464.37 million)
Full-year Adjusted EBITDA guidance increased to $245-255 million
Slower growth in payroll costs
OCF $138 million (up from $109 million a year ago)
Net debt decreased to ~$380 million
A $250 million share repurchase program was launched
Earnings fell into negative territory in 2024; the company reported positive earnings in its latest report
EPS has returned to positive territory. We expect it to remain positive.
Valuation
Forward P/E 8.7
P/S 0.7
EV/EBITDA 7.2
